Denise S B Chan

Title: **Denise S B Chan: Innovator in Pharmaceutical Compositions**

Introduction

Denise S B Chan is a prominent inventor based in Hong Kong, CN. With an impressive portfolio that includes two patents, she has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative oral taxane compositions that enhance drug absorption.

Latest Patents

Denise's most recent patents focus on oral taxane compositions and methods. These pharmaceutical compositions feature a taxane, such as paclitaxel, docetaxel, cabazitaxel, larotaxel, ortataxel, and tesetaxel, combined with a mixture of first and second surfactants. The innovative aspect of her work lies in the increased absorption of taxanes from these compositions, which surpasses the sum of absorption from each surfactant individually. The optimal ratio of the first surfactant to the second surfactant ranges from 60:40 to 85:15 by weight, ensuring that the total surfactant weight does not exceed 98% of the total weight. Additionally, suitable first surfactants include Polysorbate 80, Polysorbate 20, and caprylocaproyl polyoxylglycerides, while Polysorbate 80 or polyethyoxylated castor oil serve as effective second surfactants. The stability of these compositions can be further improved by including stabilizers such as citric acid and ascorbic acid.

Career Highlights

Denise has worked with reputable companies in the pharmaceutical sector, including Athenex HK Innovative Limited and Health Hope Pharma Limited. Her work within these organizations has been invaluable to the advancement of healthcare solutions through innovative drug formulations.

Collaborations

Throughout her career, Denise has collaborated with esteemed professionals in her field, including Ming Tsung Lee and Weng Li Yoon. These partnerships have facilitated the exchange of ideas and knowledge, further propelling her innovations in pharmaceutical development.

Conclusion

Denise S B Chan exemplifies the impact that innovative inventors can have on the pharmaceutical industry. Her contributions, particularly through her latest patents on oral taxane compositions, demonstrate her commitment to enhancing drug efficacy and patient outcomes. As she continues her work, her inventions are likely to pave the way for new advancements in the field.